Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection

NCT07706686 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

200

Enrollment

NIH

Sponsor class

Conditions

Healthy Volunteers
Dengue
Human Challenge Trial

Interventions

BIOLOGICAL: rDEN2delta30-7169

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)